News

SNO-CAP: Recapping Top News from the Society for Neuro-Oncology (SNO) Annual Meeting AS has been custom since its founding, NBTS sponsors and attends the Society for Neuro-Oncology (SNO) Annual Meeting. SNO is the top professional society for neuro-oncology research and clinical care globally. This yearly conference provides breaking news, analysis, and discussion of the emerging trends and latest scientific discoveries in the field of brain tumor research […] December 19, 2016

Brain Tumor Research Highlights: November 2016 NOTE: In October, our 2016 NBTS Scientific Summit Recap replaced our typical monthly Brain Tumor Research Highlights. We posted the September Highlights as usual. Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer […] November 15, 2016

Glioblastomas Are Addicted to Cholesterol – Can Breaking Their Dependency Stop These Tumors? Quick Summary: Defeat GBM-funded research finds that depriving tumor cells of cholesterol may be a useful clinical strategy to treat glioblastoma The brain contains more cholesterol than any other organ, accounting for about 20% of the body’s total quantity of the molecule. When brain cells are healthy and functioning normally, the amount of cholesterol is tightly […] October 19, 2016

Liquid Biopsies for Brain Tumors: Can We Improve Diagnosis, Treatment Decisions, and Research All Via One Advancement? Cover photo courtesy of the website of the National Cancer Institute (NCI) New research, supported by the Defeat GBM Research Collaborative, is paving the way for new advances in the diagnosis, monitoring, treatment planning, and research of brain tumors – both primary and metastatic. Dr. Ingo Mellinghoff – one of the Principle Investigators in the […] August 22, 2016

60 Minutes, the poliovirus, and Breakthrough Therapy Designation Since the news program “60 Minutes” first aired two segments in March 2015 focused on an early-phase clinical trial taking place at Duke University, a lot of excitement has been generated about the investigational treatment highlighted: PVS-RIPO – more commonly referred to as the re-engineered poliovirus. The excitement was well-warranted, as the results reported at […] May 13, 2016